Timeline, a Lausanne-based consumer health biotech company developing healthy aging and longevity solutions, has secured $66M (approximately €60.62M) in an oversubscribed Series D funding round. The investment was led by L’Oréal’s venture capital fund, BOLD (Business Opportunities for L’Oréal Development), and Nestlé.